A new clinical trial with Radio and Chemotherapy patients is due to commence at the end of summer 2010. It will run for twelve months at five centres of excellence in the UK and is organised by the National Cancer Research Institute.
Visit web sites dedicated to our products.
Pregnancy & Morning Sickness
NHS research proves conclusively that our product is successful in dealing with morning sickness for over 90%. See the evidence at:
Motion Sickness Clinical Trial
The MRC Spatial Disorientation Group - Imperial College of medicine, Westminster, London proves our programme highly successful against Travel Sickness. See the evidence at:
HONcode Compliance.
This site complies with the HONcode standard for trustworthy health information:
verify here.
Here you can see/check how we comply with HONcode principles.
Welcome to DAVAL.
We are the manufacturers of an audio based antiemetic proven by research and clinical trial to have astounding levels of efficacy(1) in dealing with the symptoms of nausea and vomiting and this site is here to help promote and advertise the products as well as provide quick easy access to the research data submitted to us by the credible research authorities and bodies who have independently researched our product.
We do not publish test results from our own research on our own products. It would be unethical and viewed as biased and holding little if any credibility. We do publish and make available the research information given to us by the credible and qualified authorities and bodies who have independently and without payment researched our product and published their findings.
Our product is sold under the brand names of Nevasic and MorningWell, our antiemetic product has been changing the way medical professionals think of emesis for a number of years. Our programme is registered with the MHRA and the FDA as a class 1 medical device.
Clinical trial with cancer patients to commence 2010.
A new clinical trial with Radio and Chemotherapy patients is due to commence at the end of summer 2010. It will run for twelve months at five centres of excellence in the UK and is organised by the National Cancer Research Institute.
EMESIS
Emesis is the medical term for the physical act of nausea and vomiting. It is widely accepted that the ears, brain and stomach are all closely connected and involved in the process of Emesis. The symptoms of nausea and vomiting can be experienced as the result of a condition or treatment of a condition.
Motion sickness is brought on by the elements of travel, morning sickness is brought on by the elements of pregnancy. Sickness experienced by Oncology patients is frequently as the result of Radio and Chemotherapy treatment.
Anti-emetics.
Antiemetic is the term describing a product that is used to combat the symptoms of nausea and vomiting. Irrespective of "brand" they predominantly contain a mixture of only a handful of elements proven to have an antiemetic value.
They can also prove difficult to prescribe in cases where other medicines are in practise or where more than one condition of illness prevail.
Our product - Nevasic is non-invasive, drug
free, side effect free and
without contra-indication. There
are non of the normal
"indications, side effects,
contra-indications, special
dosage instructions concerning
pregnant women or
children, or any other warnings
to be notified about.
There are normally two findings brought about by the use of our product, it works or it fails - and in either case it leaves nothing with the body, within the body or around the body.
(1) A. The NHS results in a morning sickness study proved our product over 90% successful in alleviating the symptoms of morning sickness. Full results here: http://www.morningwell.co.uk/nhsstudy.htm
B. The Westminster College of Medicine clinically trialled our product and reported it "provides significant protection against motion sickness".
B: J Travel Med. 2003 Mar-Apr,10(2):108-11 Behavioral methods of alleviating motion sickness: effectiveness of controlled breathing and a music audiotape. Yen Pik Sang FD, Billar JP, Golding JF, Gresty MA. The MRC Spatial Disorientation Group, Imperial College School of Medicine, London, United Kingdom.
Further information here: http://www.nevasic.com/whats-nevasic.html